Author Ziepert, Marita

• 2007 | Journal Article | 
  ​ ​Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens​
  Trümper, L.; Zwick, C.; Ziepert, M.; Hohloch, K.; Schmits, R.; Mohren, M. & Liersch, R. et al.​ (2007) 
  Annals of Oncology, 19(3) pp. 538​-544​.​ DOI: https://doi.org/10.1093/annonc/mdm497 
  ​Details  DOI 

• 2008 | Conference Abstract
  ​ ​Expression of intracellular ABC transporter A3 in aggressive non-Hodgkin lymphoma​
  Chapuy, B. ; Corsham, S.; Klapper, W.; Ziepert, M.; Truemper, L. H. & Wulf, G.​ (2008)
  Annals of Oncology, 19 pp. 199​-200. ​10th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2008 | Conference Abstract
  ​ ​Response adapted assignment of the number of chemotherapy cycles for the treatment of patients with Diffuse Large B-cell Lymphoma (DLBCL) is not justified: Results of the RICOVER-60 trial of the German high-grade non-hodgkin lymphoma study group (DSHNHL)​
  Schubert, J.; Ziepert, M.; Lengfelder, E.; Mohren, M.; Peter, N.; Reiser, M. & Clemens, M. et al.​ (2008)
  Onkologie, 31 
  Basel​: Karger.
  ​Details  WoS 

• 2008 | Conference Abstract
  ​ ​T-cell lymphomas in studies of the German high-grade NHL study group (DSHNHL)​
  Schmitz, N.; Ziepert, M.; Nickelsen, M.; Truemper, L. H.; Glass, B.; Loeffler, M. & Ho, A. D. et al.​ (2008)
  Annals of Oncology, 19 ​10th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2008 | Journal Article
  ​ ​Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma​
  Ziepert, M.; Schmits, R.; Truemper, L. H.; Pfreundschuh, M. & Loeffler, M.​ (2008) 
  Annals of Oncology, 19(4) pp. 752​-762​.​ DOI: https://doi.org/10.1093/annonc/mdm541 
  ​Details  DOI  PMID  PMC  WoS 

• 2008 | Journal Article
  ​ ​Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)​
  Pfreundschuh, M.; Schubert, J.; Ziepert, M.; Schmits, R.; Mohren, M.; Lengfelder, E. & Reiser, M. et al.​ (2008) 
  The Lancet Oncology, 9(2) pp. 105​-116​.​ DOI: https://doi.org/10.1016/S1470-2045(08)70002-0 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Conference Abstract
  ​ ​Mature T-/NK-cell lymphomas: Prognostic factors and treatment outcome of patients treated on studies of the German High-Grade Lymphoma Study Group (DSHNHL)​
  Schmitz, N.; Ziepert, M.; Nickelsen, M.; Wolf, S. P.; Truemper, L. H.; Loeffler, M. & Ho, A. D. et al.​ (2009)
  Journal of Clinical Oncology, 27(15) ​45th Annual Meeting of the American-Society-of-Clinical-Oncology​, Orlando, FL.
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  PMID  PMC  WoS 

• 2009 | Conference Abstract
  ​ ​Aggressive Chemotherapy (CHOEP-14) and Rituximab or High-Dose Therapy (MegaCHOEP) and Rituximab for Young, High-Risk Patients with Aggressive B-Cell Lymphoma: Results of the MegaCHOEP Trial of the German High - Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)​
  Schmitz, N.; Nickelsen, M.; Ziepert, M.; Haenel, M.; Borchmann, P.; Viardot, A. & Nickenig, C. et al.​ (2009)
  Blood, 114(22) ​51st Annual Meeting of the American-Society-of-Hematology​, New Orleans, LA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2009 | Conference Abstract
  ​ ​Outcome of Elderly Patients with DLBCL Failing R-CHOP: The Role of Rituximab and High Dose Therapy in Second Line Treatment. A Retrospective Analysis From the RICOVER 60 Trial.​
  Glass, B.; Borgerding, A.; Ziepert, M.; Nickelsen, M.; Loeffler, M.; Pfreundschuh, M. & Truemper, L. H. et al.​ (2009)
  Blood, 114(22) pp. 1430​-1431. ​51st Annual Meeting of the American-Society-of-Hematology​, New Orleans, LA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2009 | Journal Article | 
  ​ ​Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials​
  Bernd, H.-W.; Ziepert, M.; Thorns, C.; Klapper, W.; Wacker, H.-H.; Hummel, M. & Stein, H. et al.​ (2009) 
  HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 94(11) pp. 1569​-1580​.​ DOI: https://doi.org/10.3324/haematol.2009.008862 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Journal Article | 
  ​ ​Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial​
  Schoof, N.; von Bonin, F.; Zeynalova, S.; Ziepert, M.; Jung, W.; Loeffler, M. & Pfreundschuh, M. et al.​ (2009) 
  Annals of Oncology, 20(9) pp. 1548​-1554​.​ DOI: https://doi.org/10.1093/annonc/mdp110 
  ​Details  DOI  PMID  PMC  WoS 

• 2010 | Journal Article
  ​ ​A Functional Polymorphism in the NAD(P)H Oxidase Subunit CYBA Is Related to Gene Expression, Enzyme Activity, and Outcome in Non-Hodgkin Lymphoma​
  Hoffmann, M.; Schirmer, M. A.; Tzvetkov, M. V.; Kreuz, M.; Ziepert, M.; Wojnowski, L. & Kube, D. et al.​ (2010) 
  Cancer Research, 70(6) pp. 2328​-2338​.​ DOI: https://doi.org/10.1158/0008-5472.CAN-09-2388 
  ​Details  DOI  PMID  PMC  WoS 

• 2010 | Journal Article
  ​ ​Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group​
  Schmitz, N.; Truemper, L. H.; Ziepert, M.; Nickelsen, M.; Ho, A. D.; Metzner, B. & Peter, N. et al.​ (2010) 
  Blood, 116(18) pp. 3418​-3425​.​ DOI: https://doi.org/10.1182/blood-2010-02-270785 
  ​Details  DOI  PMID  PMC  WoS 

• 2010 | Journal Article
  ​ ​High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma​
  Glass, B.; Ziepert, M.; Reiser, M.; Freund, M.; Trümper, L. ; Metzner, B. & Feller, A. et al.​ (2010) 
  Annals of Oncology, 21(11) pp. 2255​-2261​.​ DOI: https://doi.org/10.1093/annonc/mdq235 
  ​Details  DOI  PMID  PMC  WoS 

• 2010 | Journal Article
  ​ ​Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL​
  Ott, G.; Ziepert, M.; Klapper, W.; Horn, H.; Szczepanowski, M.; Bernd, H.-W. & Thorns, C. et al.​ (2010) 
  Blood, 116(23) pp. 4916​-4925​.​ DOI: https://doi.org/10.1182/blood-2010-03-276766 
  ​Details  DOI  PMID  PMC  WoS 

• 2011 | Conference Abstract
  ​ ​7-year follow-up of the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)​
  Zwick, C.; Ziepert, M.; Zeynalova, S.; Lengfelder, E.; Steinhauer, H.; Clemens, M. & Nickenig, C. et al.​ (2011)
  Onkologie, 34 
  Basel​: Karger.
  ​Details  WoS 

• 2011 | Conference Abstract
  ​ ​First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant​
  d'Amore, F.; da Silva, M. G.; Leppa, S.; Relander, T.; Pezzutto, A.; Lauritzsen, G. F. & Weidmann, E. et al.​ (2011)
  Blood, 118(21) ​53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)​, San Diego, CA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

• 2011 | Conference Abstract
  ​ ​EXCELLENT OUTCOME IN AGGRESSIVE NON HODGKIN'S LYMPHOMA IN ADOLESCENTS AND YOUNG ADULTS TREATED WITH CHOP-BASED REGIMENS IN DSHNHL TRIALS: AGE IS NOT A RISK FACTOR IN PATIENTS BELOW 50 YEARS​
  Truemper, L. H.; Zeynalova, S.; Ziepert, M.; Glass, B.; Loeffler, M.; Schmitz, N. & Pfreundschuh, M.​ (2011)
  Annals of Oncology, 22 ​11th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2011 | Conference Abstract
  ​ ​CONVENTIONAL CHEMOIMMUNOTHERAPY (R-CHOEP-14) OR HIGH-DOSE THERAPY (R-MEGA-CHOEP) FOR YOUNG, HIGH-RISK PATIENTS WITH AGGRESSIVE B-CELL LYMPHOMA: FINAL RESULTS OF THE RANDOMIZED MEGA-CHOEP-TRIAL OF THE GERMAN HIGH-GRADE NON-HODGKIN LYMPHOMA STUDY GROUP (DSHNHL)​
  Schmitz, N.; Nickelsen, M.; Ziepert, M.; Borchmann, P.; Nickenig, C.; Viardot, A. & Bentz, M. et al.​ (2011)
  Annals of Oncology, 22 pp. 106​-107. ​11th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
  Oxford​: Oxford Univ Press.
  ​Details  WoS 

• 2012 | Conference Abstract
  ​ ​First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy​
  d'Amore, F.; Leppa, S.; da Silva, M. C.; Relander, T.; Brown, P. D. N.; Weidmann, E. & Lauritzsen, G. F. et al.​ (2012)
  Blood, 120(21) ​54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)​, Atlanta, GA.
  Washington​: Amer Soc Hematology.
  ​Details  WoS 

Researcher

Sort

Items per Page